Dependence of mesolimbic dopamine transmission on delta9-tetrahydrocannabinol (Q48141521)

9 February 2018

http://europepmc.org/abstract/MED/10440085

title

Dependence of mesolimbic dopamine transmission on delta9-tetrahydrocannabinol (English)

1 reference

9 February 2018

http://europepmc.org/abstract/MED/10440085

0 references

0 references

0 references

1

1 reference

9 February 2018

http://europepmc.org/abstract/MED/10440085

author name string

P Loddo

series ordinal

2

1 reference

9 February 2018

http://europepmc.org/abstract/MED/10440085

G Di Chiara

series ordinal

3

1 reference

9 February 2018

http://europepmc.org/abstract/MED/10440085

language of work or name

English

0 references

publication date

1 July 1999

1 reference

9 February 2018

http://europepmc.org/abstract/MED/10440085

published in

European Journal of Pharmacology

1 reference

9 February 2018

http://europepmc.org/abstract/MED/10440085

volume

376

1 reference

9 February 2018

http://europepmc.org/abstract/MED/10440085

issue

1-2

1 reference

9 February 2018

http://europepmc.org/abstract/MED/10440085

page(s)

23-26

1 reference

9 February 2018

http://europepmc.org/abstract/MED/10440085

cites work

Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900384-2

Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900384-2

Mesolimbic dopaminergic decline after cannabinoid withdrawal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900384-2

The role of dopamine in drug abuse viewed from the perspective of its role in motivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900384-2

Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900384-2

Drug abuse: hedonic homeostatic dysregulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900384-2

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900384-2

A dopamine-mu1 opioid link in the rat ventral tegmentum shared by palatable food (Fonzies) and non-psychostimulant drugs of abuse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900384-2

Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900384-2

Physical withdrawal in rats tolerant to delta 9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900384-2

10.1016/S0014-2999(99)00384-2

7 January 2021

Identifiers

DOI

1 reference

9 February 2018

http://europepmc.org/abstract/MED/10440085

1 reference

9 February 2018